Global Liquid Biopsy Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Liquid Biopsy market size was valued at US$ 4720 million in 2025 and is forecast to a readjusted size of US$ 15888 million by 2032 with a CAGR of 18.8% during review period.
Liquid biopsy is a molecular diagnostic technology that detects tumor-related biomarkers in body fluids such as blood, urine, or cerebrospinal fluid to enable disease screening, diagnosis, treatment monitoring, and recurrence surveillance. Compared with conventional tissue biopsy, liquid biopsy offers significant advantages including minimal invasiveness, repeatable sampling, and the ability to perform real-time dynamic monitoring. The technology primarily analyzes circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and tumor-derived RNA using advanced analytical platforms such as next-generation sequencing and digital PCR. Liquid biopsy provides a more comprehensive view of tumor molecular characteristics and heterogeneity, making it an important tool in precision medicine. With continuous advancements in genomic technologies, bioinformatics, and the growing demand for early cancer detection, liquid biopsy is increasingly becoming a key component of modern oncology diagnostics and translational research.The average gross profit margin of this product is 65%.
The continuous evolution of precision medicine is transforming clinical practice from empirical treatment toward molecular classification and personalized therapy, creating significant opportunities for liquid biopsy technologies. Increasing demand for sensitive molecular diagnostics in cancer screening, targeted therapy, and immunotherapy has positioned liquid biopsy as a critical bridge between diagnostics and treatment decision-making. Meanwhile, the declining cost of sequencing technologies and improvements in bioinformatics capabilities are enhancing the accessibility and scalability of liquid biopsy applications. Global pharmaceutical companies and research institutions are also increasing investments in early cancer detection and companion diagnostics, further accelerating technological innovation and commercialization in this field.
Despite its strong potential, liquid biopsy still faces several technical and regulatory challenges in clinical adoption. The extremely low concentration of tumor-derived molecules in body fluids requires highly sensitive and specific detection technologies, placing stringent demands on experimental workflows, analytical platforms, and data interpretation. In addition, the lack of standardized methodologies across different testing platforms may affect result consistency and clinical interpretation. Regulatory requirements for molecular diagnostic products are also becoming more rigorous, and the need for extensive clinical validation can lengthen the approval and commercialization process, potentially slowing market penetration.
Downstream demand for liquid biopsy is gradually expanding from late-stage cancer monitoring to broader clinical applications. Early cancer screening, treatment response evaluation, minimal residual disease detection, and recurrence monitoring are becoming increasingly important application areas. As precision oncology strategies continue to evolve, clinicians are relying more on dynamic molecular testing to guide treatment decisions, strengthening the role of liquid biopsy in clinical workflows. In addition, biopharmaceutical companies are increasingly adopting liquid biopsy technologies as companion diagnostic tools and research instruments in drug development, making them valuable in clinical trials and real-world evidence studies.
The upstream segment of the liquid biopsy industry mainly includes nucleic acid extraction reagents, sample preservation and stabilization reagents, sequencing reagents, and high-sensitivity molecular detection consumables. These materials directly influence detection sensitivity, stability, and experimental reproducibility, making them fundamental to overall test performance. As molecular diagnostics technologies continue to evolve, reagent suppliers are developing more efficient nucleic acid enrichment solutions and high-stability reagents to meet the demands of ultra-low concentration biomarker detection. Continuous improvements in automated sample processing systems and high-performance sequencing platforms are also driving technological advancement and scalability across the entire industry chain.
This report is a detailed and comprehensive analysis for global Liquid Biopsy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Liquid Biopsy market size and forecasts, in consumption value ($ Million), 2021-2032
Global Liquid Biopsy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Liquid Biopsy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Liquid Biopsy market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Liquid Biopsy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Liquid Biopsy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, Biocept, NeoGenomics Laboraories, Sysmex Inostics, Cynvenio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Liquid Biopsy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Liquid Biopsy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Liquid Biopsy, with revenue, gross margin, and global market share of Liquid Biopsy from 2021 to 2026.
Chapter 3, the Liquid Biopsy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Liquid Biopsy market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Liquid Biopsy.
Chapter 13, to describe Liquid Biopsy research findings and conclusion.
Liquid biopsy is a molecular diagnostic technology that detects tumor-related biomarkers in body fluids such as blood, urine, or cerebrospinal fluid to enable disease screening, diagnosis, treatment monitoring, and recurrence surveillance. Compared with conventional tissue biopsy, liquid biopsy offers significant advantages including minimal invasiveness, repeatable sampling, and the ability to perform real-time dynamic monitoring. The technology primarily analyzes circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes, and tumor-derived RNA using advanced analytical platforms such as next-generation sequencing and digital PCR. Liquid biopsy provides a more comprehensive view of tumor molecular characteristics and heterogeneity, making it an important tool in precision medicine. With continuous advancements in genomic technologies, bioinformatics, and the growing demand for early cancer detection, liquid biopsy is increasingly becoming a key component of modern oncology diagnostics and translational research.The average gross profit margin of this product is 65%.
The continuous evolution of precision medicine is transforming clinical practice from empirical treatment toward molecular classification and personalized therapy, creating significant opportunities for liquid biopsy technologies. Increasing demand for sensitive molecular diagnostics in cancer screening, targeted therapy, and immunotherapy has positioned liquid biopsy as a critical bridge between diagnostics and treatment decision-making. Meanwhile, the declining cost of sequencing technologies and improvements in bioinformatics capabilities are enhancing the accessibility and scalability of liquid biopsy applications. Global pharmaceutical companies and research institutions are also increasing investments in early cancer detection and companion diagnostics, further accelerating technological innovation and commercialization in this field.
Despite its strong potential, liquid biopsy still faces several technical and regulatory challenges in clinical adoption. The extremely low concentration of tumor-derived molecules in body fluids requires highly sensitive and specific detection technologies, placing stringent demands on experimental workflows, analytical platforms, and data interpretation. In addition, the lack of standardized methodologies across different testing platforms may affect result consistency and clinical interpretation. Regulatory requirements for molecular diagnostic products are also becoming more rigorous, and the need for extensive clinical validation can lengthen the approval and commercialization process, potentially slowing market penetration.
Downstream demand for liquid biopsy is gradually expanding from late-stage cancer monitoring to broader clinical applications. Early cancer screening, treatment response evaluation, minimal residual disease detection, and recurrence monitoring are becoming increasingly important application areas. As precision oncology strategies continue to evolve, clinicians are relying more on dynamic molecular testing to guide treatment decisions, strengthening the role of liquid biopsy in clinical workflows. In addition, biopharmaceutical companies are increasingly adopting liquid biopsy technologies as companion diagnostic tools and research instruments in drug development, making them valuable in clinical trials and real-world evidence studies.
The upstream segment of the liquid biopsy industry mainly includes nucleic acid extraction reagents, sample preservation and stabilization reagents, sequencing reagents, and high-sensitivity molecular detection consumables. These materials directly influence detection sensitivity, stability, and experimental reproducibility, making them fundamental to overall test performance. As molecular diagnostics technologies continue to evolve, reagent suppliers are developing more efficient nucleic acid enrichment solutions and high-stability reagents to meet the demands of ultra-low concentration biomarker detection. Continuous improvements in automated sample processing systems and high-performance sequencing platforms are also driving technological advancement and scalability across the entire industry chain.
This report is a detailed and comprehensive analysis for global Liquid Biopsy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Liquid Biopsy market size and forecasts, in consumption value ($ Million), 2021-2032
Global Liquid Biopsy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Liquid Biopsy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Liquid Biopsy market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Liquid Biopsy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Liquid Biopsy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include RainDanceTechnologies, Biocartis, Qiagen, Guardant Health, MDxHealth, Pathway Genomics, Biocept, NeoGenomics Laboraories, Sysmex Inostics, Cynvenio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Liquid Biopsy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Test Suite
- Equipment
- Service
- NGS Sequencing
- Digital PCR
- Real-time PCR
- Other
- Blood Sample
- Urine Sample
- Other
- Hospitals Labs
- Reference Labs
- Other
- RainDanceTechnologies
- Biocartis
- Qiagen
- Guardant Health
- MDxHealth
- Pathway Genomics
- Biocept
- NeoGenomics Laboraories
- Sysmex Inostics
- Cynvenio
- Silicon Biosystems
- Adaptive Biotechnologies
- 4D Lifetec
- Roche
- Illumina
- Exact Sciences
- Natera
- Foundation Medicine
- Thermo Fisher Scientific
- Bio-Rad Laboratories
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Liquid Biopsy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Liquid Biopsy, with revenue, gross margin, and global market share of Liquid Biopsy from 2021 to 2026.
Chapter 3, the Liquid Biopsy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Liquid Biopsy market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Liquid Biopsy.
Chapter 13, to describe Liquid Biopsy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Liquid Biopsy by Type
1.3.1 Overview: Global Liquid Biopsy Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Liquid Biopsy Consumption Value Market Share by Type in 2025
1.3.3 Test Suite
1.3.4 Equipment
1.3.5 Service
1.4 Classification of Liquid Biopsy by Technology Platform
1.4.1 Overview: Global Liquid Biopsy Market Size by Technology Platform: 2021 Versus 2025 Versus 2032
1.4.2 Global Liquid Biopsy Consumption Value Market Share by Technology Platform in 2025
1.4.3 NGS Sequencing
1.4.4 Digital PCR
1.4.5 Real-time PCR
1.4.6 Other
1.5 Classification of Liquid Biopsy by Sample
1.5.1 Overview: Global Liquid Biopsy Market Size by Sample: 2021 Versus 2025 Versus 2032
1.5.2 Global Liquid Biopsy Consumption Value Market Share by Sample in 2025
1.5.3 Blood Sample
1.5.4 Urine Sample
1.5.5 Other
1.6 Global Liquid Biopsy Market by Application
1.6.1 Overview: Global Liquid Biopsy Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospitals Labs
1.6.3 Reference Labs
1.6.4 Other
1.7 Global Liquid Biopsy Market Size & Forecast
1.8 Global Liquid Biopsy Market Size and Forecast by Region
1.8.1 Global Liquid Biopsy Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Liquid Biopsy Market Size by Region, (2021-2032)
1.8.3 North America Liquid Biopsy Market Size and Prospect (2021-2032)
1.8.4 Europe Liquid Biopsy Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Liquid Biopsy Market Size and Prospect (2021-2032)
1.8.6 South America Liquid Biopsy Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Liquid Biopsy Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 RainDanceTechnologies
2.1.1 RainDanceTechnologies Details
2.1.2 RainDanceTechnologies Major Business
2.1.3 RainDanceTechnologies Liquid Biopsy Product and Solutions
2.1.4 RainDanceTechnologies Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 RainDanceTechnologies Recent Developments and Future Plans
2.2 Biocartis
2.2.1 Biocartis Details
2.2.2 Biocartis Major Business
2.2.3 Biocartis Liquid Biopsy Product and Solutions
2.2.4 Biocartis Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Biocartis Recent Developments and Future Plans
2.3 Qiagen
2.3.1 Qiagen Details
2.3.2 Qiagen Major Business
2.3.3 Qiagen Liquid Biopsy Product and Solutions
2.3.4 Qiagen Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Qiagen Recent Developments and Future Plans
2.4 Guardant Health
2.4.1 Guardant Health Details
2.4.2 Guardant Health Major Business
2.4.3 Guardant Health Liquid Biopsy Product and Solutions
2.4.4 Guardant Health Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Guardant Health Recent Developments and Future Plans
2.5 MDxHealth
2.5.1 MDxHealth Details
2.5.2 MDxHealth Major Business
2.5.3 MDxHealth Liquid Biopsy Product and Solutions
2.5.4 MDxHealth Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 MDxHealth Recent Developments and Future Plans
2.6 Pathway Genomics
2.6.1 Pathway Genomics Details
2.6.2 Pathway Genomics Major Business
2.6.3 Pathway Genomics Liquid Biopsy Product and Solutions
2.6.4 Pathway Genomics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Pathway Genomics Recent Developments and Future Plans
2.7 Biocept
2.7.1 Biocept Details
2.7.2 Biocept Major Business
2.7.3 Biocept Liquid Biopsy Product and Solutions
2.7.4 Biocept Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Biocept Recent Developments and Future Plans
2.8 NeoGenomics Laboraories
2.8.1 NeoGenomics Laboraories Details
2.8.2 NeoGenomics Laboraories Major Business
2.8.3 NeoGenomics Laboraories Liquid Biopsy Product and Solutions
2.8.4 NeoGenomics Laboraories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 NeoGenomics Laboraories Recent Developments and Future Plans
2.9 Sysmex Inostics
2.9.1 Sysmex Inostics Details
2.9.2 Sysmex Inostics Major Business
2.9.3 Sysmex Inostics Liquid Biopsy Product and Solutions
2.9.4 Sysmex Inostics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Sysmex Inostics Recent Developments and Future Plans
2.10 Cynvenio
2.10.1 Cynvenio Details
2.10.2 Cynvenio Major Business
2.10.3 Cynvenio Liquid Biopsy Product and Solutions
2.10.4 Cynvenio Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Cynvenio Recent Developments and Future Plans
2.11 Silicon Biosystems
2.11.1 Silicon Biosystems Details
2.11.2 Silicon Biosystems Major Business
2.11.3 Silicon Biosystems Liquid Biopsy Product and Solutions
2.11.4 Silicon Biosystems Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Silicon Biosystems Recent Developments and Future Plans
2.12 Adaptive Biotechnologies
2.12.1 Adaptive Biotechnologies Details
2.12.2 Adaptive Biotechnologies Major Business
2.12.3 Adaptive Biotechnologies Liquid Biopsy Product and Solutions
2.12.4 Adaptive Biotechnologies Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Adaptive Biotechnologies Recent Developments and Future Plans
2.13 4D Lifetec
2.13.1 4D Lifetec Details
2.13.2 4D Lifetec Major Business
2.13.3 4D Lifetec Liquid Biopsy Product and Solutions
2.13.4 4D Lifetec Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 4D Lifetec Recent Developments and Future Plans
2.14 Roche
2.14.1 Roche Details
2.14.2 Roche Major Business
2.14.3 Roche Liquid Biopsy Product and Solutions
2.14.4 Roche Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Roche Recent Developments and Future Plans
2.15 Illumina
2.15.1 Illumina Details
2.15.2 Illumina Major Business
2.15.3 Illumina Liquid Biopsy Product and Solutions
2.15.4 Illumina Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Illumina Recent Developments and Future Plans
2.16 Exact Sciences
2.16.1 Exact Sciences Details
2.16.2 Exact Sciences Major Business
2.16.3 Exact Sciences Liquid Biopsy Product and Solutions
2.16.4 Exact Sciences Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Exact Sciences Recent Developments and Future Plans
2.17 Natera
2.17.1 Natera Details
2.17.2 Natera Major Business
2.17.3 Natera Liquid Biopsy Product and Solutions
2.17.4 Natera Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Natera Recent Developments and Future Plans
2.18 Foundation Medicine
2.18.1 Foundation Medicine Details
2.18.2 Foundation Medicine Major Business
2.18.3 Foundation Medicine Liquid Biopsy Product and Solutions
2.18.4 Foundation Medicine Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Foundation Medicine Recent Developments and Future Plans
2.19 Thermo Fisher Scientific
2.19.1 Thermo Fisher Scientific Details
2.19.2 Thermo Fisher Scientific Major Business
2.19.3 Thermo Fisher Scientific Liquid Biopsy Product and Solutions
2.19.4 Thermo Fisher Scientific Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.20 Bio-Rad Laboratories
2.20.1 Bio-Rad Laboratories Details
2.20.2 Bio-Rad Laboratories Major Business
2.20.3 Bio-Rad Laboratories Liquid Biopsy Product and Solutions
2.20.4 Bio-Rad Laboratories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Bio-Rad Laboratories Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Liquid Biopsy Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Liquid Biopsy by Company Revenue
3.2.2 Top 3 Liquid Biopsy Players Market Share in 2025
3.2.3 Top 6 Liquid Biopsy Players Market Share in 2025
3.3 Liquid Biopsy Market: Overall Company Footprint Analysis
3.3.1 Liquid Biopsy Market: Region Footprint
3.3.2 Liquid Biopsy Market: Company Product Type Footprint
3.3.3 Liquid Biopsy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Liquid Biopsy Consumption Value and Market Share by Type (2021-2026)
4.2 Global Liquid Biopsy Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Liquid Biopsy Consumption Value Market Share by Application (2021-2026)
5.2 Global Liquid Biopsy Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Liquid Biopsy Consumption Value by Type (2021-2032)
6.2 North America Liquid Biopsy Market Size by Application (2021-2032)
6.3 North America Liquid Biopsy Market Size by Country
6.3.1 North America Liquid Biopsy Consumption Value by Country (2021-2032)
6.3.2 United States Liquid Biopsy Market Size and Forecast (2021-2032)
6.3.3 Canada Liquid Biopsy Market Size and Forecast (2021-2032)
6.3.4 Mexico Liquid Biopsy Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Liquid Biopsy Consumption Value by Type (2021-2032)
7.2 Europe Liquid Biopsy Consumption Value by Application (2021-2032)
7.3 Europe Liquid Biopsy Market Size by Country
7.3.1 Europe Liquid Biopsy Consumption Value by Country (2021-2032)
7.3.2 Germany Liquid Biopsy Market Size and Forecast (2021-2032)
7.3.3 France Liquid Biopsy Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Liquid Biopsy Market Size and Forecast (2021-2032)
7.3.5 Russia Liquid Biopsy Market Size and Forecast (2021-2032)
7.3.6 Italy Liquid Biopsy Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Liquid Biopsy Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Liquid Biopsy Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Liquid Biopsy Market Size by Region
8.3.1 Asia-Pacific Liquid Biopsy Consumption Value by Region (2021-2032)
8.3.2 China Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.3 Japan Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.4 South Korea Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.5 India Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.7 Australia Liquid Biopsy Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Liquid Biopsy Consumption Value by Type (2021-2032)
9.2 South America Liquid Biopsy Consumption Value by Application (2021-2032)
9.3 South America Liquid Biopsy Market Size by Country
9.3.1 South America Liquid Biopsy Consumption Value by Country (2021-2032)
9.3.2 Brazil Liquid Biopsy Market Size and Forecast (2021-2032)
9.3.3 Argentina Liquid Biopsy Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Liquid Biopsy Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Liquid Biopsy Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Liquid Biopsy Market Size by Country
10.3.1 Middle East & Africa Liquid Biopsy Consumption Value by Country (2021-2032)
10.3.2 Turkey Liquid Biopsy Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Liquid Biopsy Market Size and Forecast (2021-2032)
10.3.4 UAE Liquid Biopsy Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Liquid Biopsy Market Drivers
11.2 Liquid Biopsy Market Restraints
11.3 Liquid Biopsy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Liquid Biopsy Industry Chain
12.2 Liquid Biopsy Upstream Analysis
12.3 Liquid Biopsy Midstream Analysis
12.4 Liquid Biopsy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Liquid Biopsy by Type
1.3.1 Overview: Global Liquid Biopsy Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Liquid Biopsy Consumption Value Market Share by Type in 2025
1.3.3 Test Suite
1.3.4 Equipment
1.3.5 Service
1.4 Classification of Liquid Biopsy by Technology Platform
1.4.1 Overview: Global Liquid Biopsy Market Size by Technology Platform: 2021 Versus 2025 Versus 2032
1.4.2 Global Liquid Biopsy Consumption Value Market Share by Technology Platform in 2025
1.4.3 NGS Sequencing
1.4.4 Digital PCR
1.4.5 Real-time PCR
1.4.6 Other
1.5 Classification of Liquid Biopsy by Sample
1.5.1 Overview: Global Liquid Biopsy Market Size by Sample: 2021 Versus 2025 Versus 2032
1.5.2 Global Liquid Biopsy Consumption Value Market Share by Sample in 2025
1.5.3 Blood Sample
1.5.4 Urine Sample
1.5.5 Other
1.6 Global Liquid Biopsy Market by Application
1.6.1 Overview: Global Liquid Biopsy Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Hospitals Labs
1.6.3 Reference Labs
1.6.4 Other
1.7 Global Liquid Biopsy Market Size & Forecast
1.8 Global Liquid Biopsy Market Size and Forecast by Region
1.8.1 Global Liquid Biopsy Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Liquid Biopsy Market Size by Region, (2021-2032)
1.8.3 North America Liquid Biopsy Market Size and Prospect (2021-2032)
1.8.4 Europe Liquid Biopsy Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Liquid Biopsy Market Size and Prospect (2021-2032)
1.8.6 South America Liquid Biopsy Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Liquid Biopsy Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 RainDanceTechnologies
2.1.1 RainDanceTechnologies Details
2.1.2 RainDanceTechnologies Major Business
2.1.3 RainDanceTechnologies Liquid Biopsy Product and Solutions
2.1.4 RainDanceTechnologies Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 RainDanceTechnologies Recent Developments and Future Plans
2.2 Biocartis
2.2.1 Biocartis Details
2.2.2 Biocartis Major Business
2.2.3 Biocartis Liquid Biopsy Product and Solutions
2.2.4 Biocartis Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Biocartis Recent Developments and Future Plans
2.3 Qiagen
2.3.1 Qiagen Details
2.3.2 Qiagen Major Business
2.3.3 Qiagen Liquid Biopsy Product and Solutions
2.3.4 Qiagen Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Qiagen Recent Developments and Future Plans
2.4 Guardant Health
2.4.1 Guardant Health Details
2.4.2 Guardant Health Major Business
2.4.3 Guardant Health Liquid Biopsy Product and Solutions
2.4.4 Guardant Health Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Guardant Health Recent Developments and Future Plans
2.5 MDxHealth
2.5.1 MDxHealth Details
2.5.2 MDxHealth Major Business
2.5.3 MDxHealth Liquid Biopsy Product and Solutions
2.5.4 MDxHealth Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 MDxHealth Recent Developments and Future Plans
2.6 Pathway Genomics
2.6.1 Pathway Genomics Details
2.6.2 Pathway Genomics Major Business
2.6.3 Pathway Genomics Liquid Biopsy Product and Solutions
2.6.4 Pathway Genomics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Pathway Genomics Recent Developments and Future Plans
2.7 Biocept
2.7.1 Biocept Details
2.7.2 Biocept Major Business
2.7.3 Biocept Liquid Biopsy Product and Solutions
2.7.4 Biocept Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Biocept Recent Developments and Future Plans
2.8 NeoGenomics Laboraories
2.8.1 NeoGenomics Laboraories Details
2.8.2 NeoGenomics Laboraories Major Business
2.8.3 NeoGenomics Laboraories Liquid Biopsy Product and Solutions
2.8.4 NeoGenomics Laboraories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 NeoGenomics Laboraories Recent Developments and Future Plans
2.9 Sysmex Inostics
2.9.1 Sysmex Inostics Details
2.9.2 Sysmex Inostics Major Business
2.9.3 Sysmex Inostics Liquid Biopsy Product and Solutions
2.9.4 Sysmex Inostics Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Sysmex Inostics Recent Developments and Future Plans
2.10 Cynvenio
2.10.1 Cynvenio Details
2.10.2 Cynvenio Major Business
2.10.3 Cynvenio Liquid Biopsy Product and Solutions
2.10.4 Cynvenio Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Cynvenio Recent Developments and Future Plans
2.11 Silicon Biosystems
2.11.1 Silicon Biosystems Details
2.11.2 Silicon Biosystems Major Business
2.11.3 Silicon Biosystems Liquid Biopsy Product and Solutions
2.11.4 Silicon Biosystems Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Silicon Biosystems Recent Developments and Future Plans
2.12 Adaptive Biotechnologies
2.12.1 Adaptive Biotechnologies Details
2.12.2 Adaptive Biotechnologies Major Business
2.12.3 Adaptive Biotechnologies Liquid Biopsy Product and Solutions
2.12.4 Adaptive Biotechnologies Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Adaptive Biotechnologies Recent Developments and Future Plans
2.13 4D Lifetec
2.13.1 4D Lifetec Details
2.13.2 4D Lifetec Major Business
2.13.3 4D Lifetec Liquid Biopsy Product and Solutions
2.13.4 4D Lifetec Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 4D Lifetec Recent Developments and Future Plans
2.14 Roche
2.14.1 Roche Details
2.14.2 Roche Major Business
2.14.3 Roche Liquid Biopsy Product and Solutions
2.14.4 Roche Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Roche Recent Developments and Future Plans
2.15 Illumina
2.15.1 Illumina Details
2.15.2 Illumina Major Business
2.15.3 Illumina Liquid Biopsy Product and Solutions
2.15.4 Illumina Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Illumina Recent Developments and Future Plans
2.16 Exact Sciences
2.16.1 Exact Sciences Details
2.16.2 Exact Sciences Major Business
2.16.3 Exact Sciences Liquid Biopsy Product and Solutions
2.16.4 Exact Sciences Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Exact Sciences Recent Developments and Future Plans
2.17 Natera
2.17.1 Natera Details
2.17.2 Natera Major Business
2.17.3 Natera Liquid Biopsy Product and Solutions
2.17.4 Natera Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Natera Recent Developments and Future Plans
2.18 Foundation Medicine
2.18.1 Foundation Medicine Details
2.18.2 Foundation Medicine Major Business
2.18.3 Foundation Medicine Liquid Biopsy Product and Solutions
2.18.4 Foundation Medicine Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Foundation Medicine Recent Developments and Future Plans
2.19 Thermo Fisher Scientific
2.19.1 Thermo Fisher Scientific Details
2.19.2 Thermo Fisher Scientific Major Business
2.19.3 Thermo Fisher Scientific Liquid Biopsy Product and Solutions
2.19.4 Thermo Fisher Scientific Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.20 Bio-Rad Laboratories
2.20.1 Bio-Rad Laboratories Details
2.20.2 Bio-Rad Laboratories Major Business
2.20.3 Bio-Rad Laboratories Liquid Biopsy Product and Solutions
2.20.4 Bio-Rad Laboratories Liquid Biopsy Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Bio-Rad Laboratories Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Liquid Biopsy Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Liquid Biopsy by Company Revenue
3.2.2 Top 3 Liquid Biopsy Players Market Share in 2025
3.2.3 Top 6 Liquid Biopsy Players Market Share in 2025
3.3 Liquid Biopsy Market: Overall Company Footprint Analysis
3.3.1 Liquid Biopsy Market: Region Footprint
3.3.2 Liquid Biopsy Market: Company Product Type Footprint
3.3.3 Liquid Biopsy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Liquid Biopsy Consumption Value and Market Share by Type (2021-2026)
4.2 Global Liquid Biopsy Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Liquid Biopsy Consumption Value Market Share by Application (2021-2026)
5.2 Global Liquid Biopsy Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Liquid Biopsy Consumption Value by Type (2021-2032)
6.2 North America Liquid Biopsy Market Size by Application (2021-2032)
6.3 North America Liquid Biopsy Market Size by Country
6.3.1 North America Liquid Biopsy Consumption Value by Country (2021-2032)
6.3.2 United States Liquid Biopsy Market Size and Forecast (2021-2032)
6.3.3 Canada Liquid Biopsy Market Size and Forecast (2021-2032)
6.3.4 Mexico Liquid Biopsy Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Liquid Biopsy Consumption Value by Type (2021-2032)
7.2 Europe Liquid Biopsy Consumption Value by Application (2021-2032)
7.3 Europe Liquid Biopsy Market Size by Country
7.3.1 Europe Liquid Biopsy Consumption Value by Country (2021-2032)
7.3.2 Germany Liquid Biopsy Market Size and Forecast (2021-2032)
7.3.3 France Liquid Biopsy Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Liquid Biopsy Market Size and Forecast (2021-2032)
7.3.5 Russia Liquid Biopsy Market Size and Forecast (2021-2032)
7.3.6 Italy Liquid Biopsy Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Liquid Biopsy Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Liquid Biopsy Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Liquid Biopsy Market Size by Region
8.3.1 Asia-Pacific Liquid Biopsy Consumption Value by Region (2021-2032)
8.3.2 China Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.3 Japan Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.4 South Korea Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.5 India Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Liquid Biopsy Market Size and Forecast (2021-2032)
8.3.7 Australia Liquid Biopsy Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Liquid Biopsy Consumption Value by Type (2021-2032)
9.2 South America Liquid Biopsy Consumption Value by Application (2021-2032)
9.3 South America Liquid Biopsy Market Size by Country
9.3.1 South America Liquid Biopsy Consumption Value by Country (2021-2032)
9.3.2 Brazil Liquid Biopsy Market Size and Forecast (2021-2032)
9.3.3 Argentina Liquid Biopsy Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Liquid Biopsy Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Liquid Biopsy Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Liquid Biopsy Market Size by Country
10.3.1 Middle East & Africa Liquid Biopsy Consumption Value by Country (2021-2032)
10.3.2 Turkey Liquid Biopsy Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Liquid Biopsy Market Size and Forecast (2021-2032)
10.3.4 UAE Liquid Biopsy Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Liquid Biopsy Market Drivers
11.2 Liquid Biopsy Market Restraints
11.3 Liquid Biopsy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Liquid Biopsy Industry Chain
12.2 Liquid Biopsy Upstream Analysis
12.3 Liquid Biopsy Midstream Analysis
12.4 Liquid Biopsy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Liquid Biopsy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Liquid Biopsy Consumption Value by Technology Platform, (USD Million), 2021 & 2025 & 2032
Table 3. Global Liquid Biopsy Consumption Value by Sample, (USD Million), 2021 & 2025 & 2032
Table 4. Global Liquid Biopsy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Liquid Biopsy Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Liquid Biopsy Consumption Value by Region (2027-2032) & (USD Million)
Table 7. RainDanceTechnologies Company Information, Head Office, and Major Competitors
Table 8. RainDanceTechnologies Major Business
Table 9. RainDanceTechnologies Liquid Biopsy Product and Solutions
Table 10. RainDanceTechnologies Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. RainDanceTechnologies Recent Developments and Future Plans
Table 12. Biocartis Company Information, Head Office, and Major Competitors
Table 13. Biocartis Major Business
Table 14. Biocartis Liquid Biopsy Product and Solutions
Table 15. Biocartis Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Biocartis Recent Developments and Future Plans
Table 17. Qiagen Company Information, Head Office, and Major Competitors
Table 18. Qiagen Major Business
Table 19. Qiagen Liquid Biopsy Product and Solutions
Table 20. Qiagen Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Guardant Health Company Information, Head Office, and Major Competitors
Table 22. Guardant Health Major Business
Table 23. Guardant Health Liquid Biopsy Product and Solutions
Table 24. Guardant Health Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Guardant Health Recent Developments and Future Plans
Table 26. MDxHealth Company Information, Head Office, and Major Competitors
Table 27. MDxHealth Major Business
Table 28. MDxHealth Liquid Biopsy Product and Solutions
Table 29. MDxHealth Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. MDxHealth Recent Developments and Future Plans
Table 31. Pathway Genomics Company Information, Head Office, and Major Competitors
Table 32. Pathway Genomics Major Business
Table 33. Pathway Genomics Liquid Biopsy Product and Solutions
Table 34. Pathway Genomics Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Pathway Genomics Recent Developments and Future Plans
Table 36. Biocept Company Information, Head Office, and Major Competitors
Table 37. Biocept Major Business
Table 38. Biocept Liquid Biopsy Product and Solutions
Table 39. Biocept Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Biocept Recent Developments and Future Plans
Table 41. NeoGenomics Laboraories Company Information, Head Office, and Major Competitors
Table 42. NeoGenomics Laboraories Major Business
Table 43. NeoGenomics Laboraories Liquid Biopsy Product and Solutions
Table 44. NeoGenomics Laboraories Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. NeoGenomics Laboraories Recent Developments and Future Plans
Table 46. Sysmex Inostics Company Information, Head Office, and Major Competitors
Table 47. Sysmex Inostics Major Business
Table 48. Sysmex Inostics Liquid Biopsy Product and Solutions
Table 49. Sysmex Inostics Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Sysmex Inostics Recent Developments and Future Plans
Table 51. Cynvenio Company Information, Head Office, and Major Competitors
Table 52. Cynvenio Major Business
Table 53. Cynvenio Liquid Biopsy Product and Solutions
Table 54. Cynvenio Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Cynvenio Recent Developments and Future Plans
Table 56. Silicon Biosystems Company Information, Head Office, and Major Competitors
Table 57. Silicon Biosystems Major Business
Table 58. Silicon Biosystems Liquid Biopsy Product and Solutions
Table 59. Silicon Biosystems Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Silicon Biosystems Recent Developments and Future Plans
Table 61. Adaptive Biotechnologies Company Information, Head Office, and Major Competitors
Table 62. Adaptive Biotechnologies Major Business
Table 63. Adaptive Biotechnologies Liquid Biopsy Product and Solutions
Table 64. Adaptive Biotechnologies Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Adaptive Biotechnologies Recent Developments and Future Plans
Table 66. 4D Lifetec Company Information, Head Office, and Major Competitors
Table 67. 4D Lifetec Major Business
Table 68. 4D Lifetec Liquid Biopsy Product and Solutions
Table 69. 4D Lifetec Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. 4D Lifetec Recent Developments and Future Plans
Table 71. Roche Company Information, Head Office, and Major Competitors
Table 72. Roche Major Business
Table 73. Roche Liquid Biopsy Product and Solutions
Table 74. Roche Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Roche Recent Developments and Future Plans
Table 76. Illumina Company Information, Head Office, and Major Competitors
Table 77. Illumina Major Business
Table 78. Illumina Liquid Biopsy Product and Solutions
Table 79. Illumina Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Illumina Recent Developments and Future Plans
Table 81. Exact Sciences Company Information, Head Office, and Major Competitors
Table 82. Exact Sciences Major Business
Table 83. Exact Sciences Liquid Biopsy Product and Solutions
Table 84. Exact Sciences Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Exact Sciences Recent Developments and Future Plans
Table 86. Natera Company Information, Head Office, and Major Competitors
Table 87. Natera Major Business
Table 88. Natera Liquid Biopsy Product and Solutions
Table 89. Natera Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Natera Recent Developments and Future Plans
Table 91. Foundation Medicine Company Information, Head Office, and Major Competitors
Table 92. Foundation Medicine Major Business
Table 93. Foundation Medicine Liquid Biopsy Product and Solutions
Table 94. Foundation Medicine Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Foundation Medicine Recent Developments and Future Plans
Table 96. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 97. Thermo Fisher Scientific Major Business
Table 98. Thermo Fisher Scientific Liquid Biopsy Product and Solutions
Table 99. Thermo Fisher Scientific Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Thermo Fisher Scientific Recent Developments and Future Plans
Table 101. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 102. Bio-Rad Laboratories Major Business
Table 103. Bio-Rad Laboratories Liquid Biopsy Product and Solutions
Table 104. Bio-Rad Laboratories Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Bio-Rad Laboratories Recent Developments and Future Plans
Table 106. Global Liquid Biopsy Revenue (USD Million) by Players (2021-2026)
Table 107. Global Liquid Biopsy Revenue Share by Players (2021-2026)
Table 108. Breakdown of Liquid Biopsy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 109. Market Position of Players in Liquid Biopsy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 110. Head Office of Key Liquid Biopsy Players
Table 111. Liquid Biopsy Market: Company Product Type Footprint
Table 112. Liquid Biopsy Market: Company Product Application Footprint
Table 113. Liquid Biopsy New Market Entrants and Barriers to Market Entry
Table 114. Liquid Biopsy Mergers, Acquisition, Agreements, and Collaborations
Table 115. Global Liquid Biopsy Consumption Value (USD Million) by Type (2021-2026)
Table 116. Global Liquid Biopsy Consumption Value Share by Type (2021-2026)
Table 117. Global Liquid Biopsy Consumption Value Forecast by Type (2027-2032)
Table 118. Global Liquid Biopsy Consumption Value by Application (2021-2026)
Table 119. Global Liquid Biopsy Consumption Value Forecast by Application (2027-2032)
Table 120. North America Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 121. North America Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 122. North America Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 123. North America Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 124. North America Liquid Biopsy Consumption Value by Country (2021-2026) & (USD Million)
Table 125. North America Liquid Biopsy Consumption Value by Country (2027-2032) & (USD Million)
Table 126. Europe Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 127. Europe Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 128. Europe Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 129. Europe Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 130. Europe Liquid Biopsy Consumption Value by Country (2021-2026) & (USD Million)
Table 131. Europe Liquid Biopsy Consumption Value by Country (2027-2032) & (USD Million)
Table 132. Asia-Pacific Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 133. Asia-Pacific Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 134. Asia-Pacific Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 135. Asia-Pacific Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 136. Asia-Pacific Liquid Biopsy Consumption Value by Region (2021-2026) & (USD Million)
Table 137. Asia-Pacific Liquid Biopsy Consumption Value by Region (2027-2032) & (USD Million)
Table 138. South America Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 139. South America Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 140. South America Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 141. South America Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 142. South America Liquid Biopsy Consumption Value by Country (2021-2026) & (USD Million)
Table 143. South America Liquid Biopsy Consumption Value by Country (2027-2032) & (USD Million)
Table 144. Middle East & Africa Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 145. Middle East & Africa Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 146. Middle East & Africa Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 147. Middle East & Africa Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 148. Middle East & Africa Liquid Biopsy Consumption Value by Country (2021-2026) & (USD Million)
Table 149. Middle East & Africa Liquid Biopsy Consumption Value by Country (2027-2032) & (USD Million)
Table 150. Global Key Players of Liquid Biopsy Upstream (Raw Materials)
Table 151. Global Liquid Biopsy Typical Customers
Table 1. Global Liquid Biopsy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Liquid Biopsy Consumption Value by Technology Platform, (USD Million), 2021 & 2025 & 2032
Table 3. Global Liquid Biopsy Consumption Value by Sample, (USD Million), 2021 & 2025 & 2032
Table 4. Global Liquid Biopsy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Liquid Biopsy Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Liquid Biopsy Consumption Value by Region (2027-2032) & (USD Million)
Table 7. RainDanceTechnologies Company Information, Head Office, and Major Competitors
Table 8. RainDanceTechnologies Major Business
Table 9. RainDanceTechnologies Liquid Biopsy Product and Solutions
Table 10. RainDanceTechnologies Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. RainDanceTechnologies Recent Developments and Future Plans
Table 12. Biocartis Company Information, Head Office, and Major Competitors
Table 13. Biocartis Major Business
Table 14. Biocartis Liquid Biopsy Product and Solutions
Table 15. Biocartis Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Biocartis Recent Developments and Future Plans
Table 17. Qiagen Company Information, Head Office, and Major Competitors
Table 18. Qiagen Major Business
Table 19. Qiagen Liquid Biopsy Product and Solutions
Table 20. Qiagen Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Guardant Health Company Information, Head Office, and Major Competitors
Table 22. Guardant Health Major Business
Table 23. Guardant Health Liquid Biopsy Product and Solutions
Table 24. Guardant Health Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Guardant Health Recent Developments and Future Plans
Table 26. MDxHealth Company Information, Head Office, and Major Competitors
Table 27. MDxHealth Major Business
Table 28. MDxHealth Liquid Biopsy Product and Solutions
Table 29. MDxHealth Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. MDxHealth Recent Developments and Future Plans
Table 31. Pathway Genomics Company Information, Head Office, and Major Competitors
Table 32. Pathway Genomics Major Business
Table 33. Pathway Genomics Liquid Biopsy Product and Solutions
Table 34. Pathway Genomics Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Pathway Genomics Recent Developments and Future Plans
Table 36. Biocept Company Information, Head Office, and Major Competitors
Table 37. Biocept Major Business
Table 38. Biocept Liquid Biopsy Product and Solutions
Table 39. Biocept Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Biocept Recent Developments and Future Plans
Table 41. NeoGenomics Laboraories Company Information, Head Office, and Major Competitors
Table 42. NeoGenomics Laboraories Major Business
Table 43. NeoGenomics Laboraories Liquid Biopsy Product and Solutions
Table 44. NeoGenomics Laboraories Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. NeoGenomics Laboraories Recent Developments and Future Plans
Table 46. Sysmex Inostics Company Information, Head Office, and Major Competitors
Table 47. Sysmex Inostics Major Business
Table 48. Sysmex Inostics Liquid Biopsy Product and Solutions
Table 49. Sysmex Inostics Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Sysmex Inostics Recent Developments and Future Plans
Table 51. Cynvenio Company Information, Head Office, and Major Competitors
Table 52. Cynvenio Major Business
Table 53. Cynvenio Liquid Biopsy Product and Solutions
Table 54. Cynvenio Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Cynvenio Recent Developments and Future Plans
Table 56. Silicon Biosystems Company Information, Head Office, and Major Competitors
Table 57. Silicon Biosystems Major Business
Table 58. Silicon Biosystems Liquid Biopsy Product and Solutions
Table 59. Silicon Biosystems Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Silicon Biosystems Recent Developments and Future Plans
Table 61. Adaptive Biotechnologies Company Information, Head Office, and Major Competitors
Table 62. Adaptive Biotechnologies Major Business
Table 63. Adaptive Biotechnologies Liquid Biopsy Product and Solutions
Table 64. Adaptive Biotechnologies Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Adaptive Biotechnologies Recent Developments and Future Plans
Table 66. 4D Lifetec Company Information, Head Office, and Major Competitors
Table 67. 4D Lifetec Major Business
Table 68. 4D Lifetec Liquid Biopsy Product and Solutions
Table 69. 4D Lifetec Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. 4D Lifetec Recent Developments and Future Plans
Table 71. Roche Company Information, Head Office, and Major Competitors
Table 72. Roche Major Business
Table 73. Roche Liquid Biopsy Product and Solutions
Table 74. Roche Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Roche Recent Developments and Future Plans
Table 76. Illumina Company Information, Head Office, and Major Competitors
Table 77. Illumina Major Business
Table 78. Illumina Liquid Biopsy Product and Solutions
Table 79. Illumina Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Illumina Recent Developments and Future Plans
Table 81. Exact Sciences Company Information, Head Office, and Major Competitors
Table 82. Exact Sciences Major Business
Table 83. Exact Sciences Liquid Biopsy Product and Solutions
Table 84. Exact Sciences Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Exact Sciences Recent Developments and Future Plans
Table 86. Natera Company Information, Head Office, and Major Competitors
Table 87. Natera Major Business
Table 88. Natera Liquid Biopsy Product and Solutions
Table 89. Natera Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Natera Recent Developments and Future Plans
Table 91. Foundation Medicine Company Information, Head Office, and Major Competitors
Table 92. Foundation Medicine Major Business
Table 93. Foundation Medicine Liquid Biopsy Product and Solutions
Table 94. Foundation Medicine Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Foundation Medicine Recent Developments and Future Plans
Table 96. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 97. Thermo Fisher Scientific Major Business
Table 98. Thermo Fisher Scientific Liquid Biopsy Product and Solutions
Table 99. Thermo Fisher Scientific Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. Thermo Fisher Scientific Recent Developments and Future Plans
Table 101. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 102. Bio-Rad Laboratories Major Business
Table 103. Bio-Rad Laboratories Liquid Biopsy Product and Solutions
Table 104. Bio-Rad Laboratories Liquid Biopsy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Bio-Rad Laboratories Recent Developments and Future Plans
Table 106. Global Liquid Biopsy Revenue (USD Million) by Players (2021-2026)
Table 107. Global Liquid Biopsy Revenue Share by Players (2021-2026)
Table 108. Breakdown of Liquid Biopsy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 109. Market Position of Players in Liquid Biopsy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 110. Head Office of Key Liquid Biopsy Players
Table 111. Liquid Biopsy Market: Company Product Type Footprint
Table 112. Liquid Biopsy Market: Company Product Application Footprint
Table 113. Liquid Biopsy New Market Entrants and Barriers to Market Entry
Table 114. Liquid Biopsy Mergers, Acquisition, Agreements, and Collaborations
Table 115. Global Liquid Biopsy Consumption Value (USD Million) by Type (2021-2026)
Table 116. Global Liquid Biopsy Consumption Value Share by Type (2021-2026)
Table 117. Global Liquid Biopsy Consumption Value Forecast by Type (2027-2032)
Table 118. Global Liquid Biopsy Consumption Value by Application (2021-2026)
Table 119. Global Liquid Biopsy Consumption Value Forecast by Application (2027-2032)
Table 120. North America Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 121. North America Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 122. North America Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 123. North America Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 124. North America Liquid Biopsy Consumption Value by Country (2021-2026) & (USD Million)
Table 125. North America Liquid Biopsy Consumption Value by Country (2027-2032) & (USD Million)
Table 126. Europe Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 127. Europe Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 128. Europe Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 129. Europe Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 130. Europe Liquid Biopsy Consumption Value by Country (2021-2026) & (USD Million)
Table 131. Europe Liquid Biopsy Consumption Value by Country (2027-2032) & (USD Million)
Table 132. Asia-Pacific Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 133. Asia-Pacific Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 134. Asia-Pacific Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 135. Asia-Pacific Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 136. Asia-Pacific Liquid Biopsy Consumption Value by Region (2021-2026) & (USD Million)
Table 137. Asia-Pacific Liquid Biopsy Consumption Value by Region (2027-2032) & (USD Million)
Table 138. South America Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 139. South America Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 140. South America Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 141. South America Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 142. South America Liquid Biopsy Consumption Value by Country (2021-2026) & (USD Million)
Table 143. South America Liquid Biopsy Consumption Value by Country (2027-2032) & (USD Million)
Table 144. Middle East & Africa Liquid Biopsy Consumption Value by Type (2021-2026) & (USD Million)
Table 145. Middle East & Africa Liquid Biopsy Consumption Value by Type (2027-2032) & (USD Million)
Table 146. Middle East & Africa Liquid Biopsy Consumption Value by Application (2021-2026) & (USD Million)
Table 147. Middle East & Africa Liquid Biopsy Consumption Value by Application (2027-2032) & (USD Million)
Table 148. Middle East & Africa Liquid Biopsy Consumption Value by Country (2021-2026) & (USD Million)
Table 149. Middle East & Africa Liquid Biopsy Consumption Value by Country (2027-2032) & (USD Million)
Table 150. Global Key Players of Liquid Biopsy Upstream (Raw Materials)
Table 151. Global Liquid Biopsy Typical Customers
LIST OF FIGURES
Figure 1. Liquid Biopsy Picture
Figure 2. Global Liquid Biopsy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Liquid Biopsy Consumption Value Market Share by Type in 2025
Figure 4. Test Suite
Figure 5. Equipment
Figure 6. Service
Figure 7. Global Liquid Biopsy Consumption Value by Technology Platform, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Liquid Biopsy Consumption Value Market Share by Technology Platform in 2025
Figure 9. NGS Sequencing
Figure 10. Digital PCR
Figure 11. Real-time PCR
Figure 12. Other
Figure 13. Global Liquid Biopsy Consumption Value by Sample, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Liquid Biopsy Consumption Value Market Share by Sample in 2025
Figure 15. Blood Sample
Figure 16. Urine Sample
Figure 17. Other
Figure 18. Global Liquid Biopsy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Liquid Biopsy Consumption Value Market Share by Application in 2025
Figure 20. Hospitals Labs Picture
Figure 21. Reference Labs Picture
Figure 22. Other Picture
Figure 23. Global Liquid Biopsy Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 24. Global Liquid Biopsy Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 25. Global Market Liquid Biopsy Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 26. Global Liquid Biopsy Consumption Value Market Share by Region (2021-2032)
Figure 27. Global Liquid Biopsy Consumption Value Market Share by Region in 2025
Figure 28. North America Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 29. Europe Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 30. Asia-Pacific Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 31. South America Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 32. Middle East & Africa Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 33. Company Three Recent Developments and Future Plans
Figure 34. Global Liquid Biopsy Revenue Share by Players in 2025
Figure 35. Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 36. Market Share of Liquid Biopsy by Player Revenue in 2025
Figure 37. Top 3 Liquid Biopsy Players Market Share in 2025
Figure 38. Top 6 Liquid Biopsy Players Market Share in 2025
Figure 39. Global Liquid Biopsy Consumption Value Share by Type (2021-2026)
Figure 40. Global Liquid Biopsy Market Share Forecast by Type (2027-2032)
Figure 41. Global Liquid Biopsy Consumption Value Share by Application (2021-2026)
Figure 42. Global Liquid Biopsy Market Share Forecast by Application (2027-2032)
Figure 43. North America Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 44. North America Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 45. North America Liquid Biopsy Consumption Value Market Share by Country (2021-2032)
Figure 46. United States Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 50. Europe Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 51. Europe Liquid Biopsy Consumption Value Market Share by Country (2021-2032)
Figure 52. Germany Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 53. France Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 54. United Kingdom Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 55. Russia Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 56. Italy Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 57. Asia-Pacific Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 58. Asia-Pacific Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 59. Asia-Pacific Liquid Biopsy Consumption Value Market Share by Region (2021-2032)
Figure 60. China Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 63. India Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 66. South America Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 67. South America Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 68. South America Liquid Biopsy Consumption Value Market Share by Country (2021-2032)
Figure 69. Brazil Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 70. Argentina Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 71. Middle East & Africa Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 72. Middle East & Africa Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 73. Middle East & Africa Liquid Biopsy Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 75. Saudi Arabia Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 76. UAE Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 77. Liquid Biopsy Market Drivers
Figure 78. Liquid Biopsy Market Restraints
Figure 79. Liquid Biopsy Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Liquid Biopsy Industrial Chain
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Liquid Biopsy Picture
Figure 2. Global Liquid Biopsy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Liquid Biopsy Consumption Value Market Share by Type in 2025
Figure 4. Test Suite
Figure 5. Equipment
Figure 6. Service
Figure 7. Global Liquid Biopsy Consumption Value by Technology Platform, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Liquid Biopsy Consumption Value Market Share by Technology Platform in 2025
Figure 9. NGS Sequencing
Figure 10. Digital PCR
Figure 11. Real-time PCR
Figure 12. Other
Figure 13. Global Liquid Biopsy Consumption Value by Sample, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Liquid Biopsy Consumption Value Market Share by Sample in 2025
Figure 15. Blood Sample
Figure 16. Urine Sample
Figure 17. Other
Figure 18. Global Liquid Biopsy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Liquid Biopsy Consumption Value Market Share by Application in 2025
Figure 20. Hospitals Labs Picture
Figure 21. Reference Labs Picture
Figure 22. Other Picture
Figure 23. Global Liquid Biopsy Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 24. Global Liquid Biopsy Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 25. Global Market Liquid Biopsy Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 26. Global Liquid Biopsy Consumption Value Market Share by Region (2021-2032)
Figure 27. Global Liquid Biopsy Consumption Value Market Share by Region in 2025
Figure 28. North America Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 29. Europe Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 30. Asia-Pacific Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 31. South America Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 32. Middle East & Africa Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 33. Company Three Recent Developments and Future Plans
Figure 34. Global Liquid Biopsy Revenue Share by Players in 2025
Figure 35. Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 36. Market Share of Liquid Biopsy by Player Revenue in 2025
Figure 37. Top 3 Liquid Biopsy Players Market Share in 2025
Figure 38. Top 6 Liquid Biopsy Players Market Share in 2025
Figure 39. Global Liquid Biopsy Consumption Value Share by Type (2021-2026)
Figure 40. Global Liquid Biopsy Market Share Forecast by Type (2027-2032)
Figure 41. Global Liquid Biopsy Consumption Value Share by Application (2021-2026)
Figure 42. Global Liquid Biopsy Market Share Forecast by Application (2027-2032)
Figure 43. North America Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 44. North America Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 45. North America Liquid Biopsy Consumption Value Market Share by Country (2021-2032)
Figure 46. United States Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 50. Europe Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 51. Europe Liquid Biopsy Consumption Value Market Share by Country (2021-2032)
Figure 52. Germany Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 53. France Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 54. United Kingdom Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 55. Russia Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 56. Italy Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 57. Asia-Pacific Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 58. Asia-Pacific Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 59. Asia-Pacific Liquid Biopsy Consumption Value Market Share by Region (2021-2032)
Figure 60. China Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 63. India Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 66. South America Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 67. South America Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 68. South America Liquid Biopsy Consumption Value Market Share by Country (2021-2032)
Figure 69. Brazil Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 70. Argentina Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 71. Middle East & Africa Liquid Biopsy Consumption Value Market Share by Type (2021-2032)
Figure 72. Middle East & Africa Liquid Biopsy Consumption Value Market Share by Application (2021-2032)
Figure 73. Middle East & Africa Liquid Biopsy Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 75. Saudi Arabia Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 76. UAE Liquid Biopsy Consumption Value (2021-2032) & (USD Million)
Figure 77. Liquid Biopsy Market Drivers
Figure 78. Liquid Biopsy Market Restraints
Figure 79. Liquid Biopsy Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Liquid Biopsy Industrial Chain
Figure 82. Methodology
Figure 83. Research Process and Data Source
